Funding boost for dementia research
Dementia researchers at the University of Southampton have received a welcome funding boost for two pioneering studies to shed more light on Alzheimer’s disease.
Alzheimer’s disease affects around half a million people in the UK today, causing devastating symptoms of memory loss, confusion, personality change and a gradual decline in the ability of someone to manage daily life. Alzheimer’s is the most common cause of dementia, a condition which affects two in every three care home residents and around a quarter of everyone currently in a hospital bed in the UK.
Alzheimer’s is a brain disease caused by an abnormal build-up of proteins in the brain that interfere with the normal functioning of brain cells. Through cutting-edge research, scientists are learning more about the damaging process that happen in the brain in Alzheimer’s, in a bid to develop effective new treatments to help those affected.
Dr Mariana Vargas-Caballero, a lecturer at the University’s Institute of Life Sciences, has been awarded £48,000 for an innovative 18-month project getting underway next month. The study aims to shed more light on two of the hallmark abnormal proteins that build up in the brain in Alzheimer’s, called amyloid and tau. She will use mice bred to develop a build-up of these proteins to study how they affect the health of brain connections. By understanding more about this complex process, Dr Vargas-Caballero aims to gain new insights into how to develop medicines that could maintain the health of nerve cells for longer in diseases like Alzheimer’s.
Dr Ruihua Hou, a psychiatrist and clinical researcher at the University’s Faculty of Medicine, has secured £50,000 of funding from the charity for a two-year study due to start later in the year. The study will use MRI brain scanning techniques in people with Alzheimer’s disease to study a key area of the brain implicated in the disease.
She said: “For some time, there has been evidence of degeneration in a tiny area of the brain called locus coeruleus in Alzheimer’s disease. So far, most evidence comes from animal and post-mortem studies and we don’t have reliable ways of measuring how well the locus coeruleus is working in living people. Our research group has recently developed a new approach to directly measure changes in the locus coeruleus using MRI brain scans. This new funding will allow us to detect changes within the locus coeruleus and help us understand the role of this area of the brain in Alzheimer’s disease. The project will help us identify new approaches to assist in the diagnosis of Alzheimer’s, as well as potentially exploring how we could target changes in the locus coeruleus as a way to treat the disease.”
Dr Rosa Sancho, Head of Research at Alzheimer’s Research UK, said: “Thanks to funding from charities like Alzheimer’s Research UK, our understanding about what happens in the brain in Alzheimer’s is growing rapidly but there are still important questions to be answered. We’re pleased to be able to award new funding to researchers in Southampton to start to tackle some of the important questions that still remain about the brain and how it’s damaged in Alzheimer’s. With 850,000 people in the UK living with dementia today, including over 2,500 in Southampton alone, we must continue to invest in the most cutting-edge science that can transform lives today and in the future. As we rely entirely on public donations to fund our research, it’s important to raise awareness of the diseases that cause dementia and the progress that can be made through research.”